Sponsor: Tyme, Inc
Enrolling in our Bronx locations. Tyme 2016b: A phase 1b/2 trial of the SM88 treatment regimen in patietns with prostate cancer.
Call us (855) 528-7322
Enrolling in our Bronx locations. Tyme 2016b: A phase 1b/2 trial of the SM88 treatment regimen in patietns with prostate cancer.